.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The FLORALI randomized trial compared high-flow nasal oxygen, standard oxygen and noninvasive positive-pressure ventilation as initial support for patients with acute hypoxemic respiratory failure. The primary composite endpoint did not significantly differ across groups, but high-flow oxygen was associated with lower 90-day mortality in the overall cohort and better ventilator-free days in some analyses. The study helped establish high-flow nasal cannula as an important noninvasive respiratory-support modality. For internists, patient selection and close monitoring are essential. High-flow oxygen can improve oxygen delivery and patient comfort, but failure should not be allowed to delay escalation to invasive ventilation in patients with worsening respiratory effort, hemodynamic instability or persistent hypoxemia. The therapy is best used within a structured reassessment pathway. In practice, the decision should combine oxygenation, work of breathing, mental status, hemodynamics and trajectory rather than relying on a single saturation value.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The FLORALI randomized trial compared high-flow nasal oxygen, standard oxygen and noninvasive positive-pressure ventilation as initial support for patients with acute hypoxemic respiratory failure. The primary composite endpoint did not significantly differ across groups, but high-flow oxygen was associated with lower 90-day mortality in the overall cohort and better ventilator-free days in some analyses. The study helped establish high-flow nasal cannula as an important noninvasive respiratory-support modality. For internists, patient selection and close monitoring are essential. High-flow oxygen can improve oxygen delivery and patient comfort, but failure should not be allowed to delay escalation to invasive ventilation in patients with worsening respiratory effort, hemodynamic instability or persistent hypoxemia. The therapy is best used within a structured reassessment pathway. In practice, the decision should combine oxygenation, work of breathing, mental status, hemodynamics and trajectory rather than relying on a single saturation value.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
